EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    The Role of Automation in Pharmaceutical Manufacturing

    Modern pharmaceutics gained momentum through technological progress which primarily involved automation in pharmaceutical production processes The drug development process now produces major changes in drug manufacturing pipeline operations from start to finish delivery to marketplaces The pharmaceutical industry requires better efficiency together with precision and speed and therefore automation...

    Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease

    Alzheimers disease ADis a neurological disorder that is responsible for brain atrophy and neuronal degeneration resulting in a decline in thinking ability and behaviour The progressive neurodegeneration leads to memory loss or dementia which makes it difficult to carry out daytoday tasks and it also has an impact on the socializing ability of the individual

    Advancing Sterile API Manufacturing: Innovations in Next-Generation

    For most of the industrys history sterility was a finishedproduct concern Active ingredients were synthesised under conventional good manufacturing practice shipped as bulk powders and rendered sterile only when they reached the fillfinish line usually through filtration or terminal heat That model served simple watersoluble injectables well It serves todays portfolio poorly

    mRNA Technology: Unlocking New Possibilities In Therapeutics Beyond Vaccines

    In the last few years the mRNA has emerged as a discovery of the century in what concerns biotechnology and medicine Although it has emerged on the global level during the search for COVID vaccines it is used in many other ways Scientists and big pharmacy companies are now investigating virtually all possible uses of mRNA from highly targeted treatments to diseases that had no cure before

    Data-Driven Pharma: Enterprise AI Strategies for R&D, Quality, and Operations

    Few boardrooms in European pharma still need convincing that artificial intelligence matters The argument has moved on The uncomfortable question now facing chief executives chief scientific officers and heads of operations is why an organisation running eighty or ninety AI initiatives can rarely point to eighty or ninety changes in how it discovers releases or ships a medicine

    Blockchain in Pharma: Strengthening Drug Traceability, Compliance, and Supply Chain Security

    For most of the last decade the European pharmaceutical industry framed supply chain integrity as a packaging problem Put a unique identifier on every pack seal it with an antitampering device check it at the point of dispensing and the falsified medicine threat would be contained Since February that model has been law across the European Union and it has worked better than many sceptics predicte...

TOP ARTICLES

press releases Read more...

NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury

NervGen NASDAQ NGEN a latestage clinical biopharmaceutical company developing firstinclass neuroreparative therapeutics for spinal cord injury SCI and other neurotraumatic and neurologic conditions today announced

Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease

Lineage Cell Therapeutics Inc NYSE American and TASE LCTX a clinicalstage biotechnology company developing allogeneic off the shelf cell therapies for serious medical conditions today announced that the Company has acquired NeuroAirmid

Instem and Sable Bio Launch Partnership to Accelerate Target Risk Assessment Through AI-Powered Scientific Intelligence

Instem a leading provider of software solutions and scientific services for drug discovery and development today announced a strategic partnership with Sable Bio to transform how biopharmaceutical organizations evaluate target safety and risk

Laboratoires Pierre Fabre and XtalPi Announce an AI-Driven Collaboration Focused on Drug Discovery

Laboratoires Pierre Fabre and XtalPi are pleased to announce an agreement under which they will collaborate on the discovery of novel clinical candidates across a number of research programs in the field of oncology potentially dermatology and rare diseases

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

25 - 25

Nov 2026

What’s Next for Pharma Marketing in 2027

Landesmuseum Zürich, Zurich, S...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

01 - 03

Dec 2026

Pharmaceutical Launch Excellence Summit

Novotel Amsterdam City, Nether...

01 - 03

Dec 2026

10th Antifibrotic Drug Development

Boston, MA at the Hotel Common...

02 - 04

Dec 2026

Genome Informatics 2026

Wellcome Genome Campus, UK

LATEST NEWS Read more...

Immuneering and Astellas to Evaluate Combination Treatments for CLDN18.2-Expressing Pancreatic Cancer

Immuneering Corporation Nasdaq IMRX has entered into a clinical trial collaboration and supply agreement with Astellas Pharma Global Development Inc a subsidiary of Astellas Pharma Inc TSE to evaluate combination treatments for patients with pancreatic cancer whose tumours express CLDN

Takeda Launches ORZEYFUL (Oveporexton), the First Orexin Agonist for Narcolepsy Type 1, in the US

Takeda TSE NYSE TAK has announced the US launch of ORZEYFUL oveporexton CIV now available by prescription for adults with narcolepsy type NT also known as narcolepsy with cataplexy The medicine is the first and only orexin agonist available for this condition

Applied Biologics Partners with Dartmouth College on Computational Protein Engineering Research

Applied Biologics a biopharmaceutical company developing biologic and gene therapies for serious diseases has entered into a research collaboration agreement with Dartmouth Colleges Thayer School of Engineering

Onco-Innovations Agrees to Terminate Performance-Based Funding Arrangement with Sorbie

OncoInnovations Limited Cboe ONCO has entered into an agreement with Sorbie Bornholm LP SBLP and Sorbie Investments LLP SILP to terminate its previously announced performancebased funding arrangement which was disclosed on July

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Oncovita a French biotechnology company specialized in therapeutic and prophylactic vaccines today announced that the European Commission has granted orphan medicinal product designation to its lead investigational candidate MVdeltaC for the treatment of mesothelioma

DeepLife and 3billion partner to discover small-molecule therapeutics against genetic modifier targets across multiple diseases

DeepLife a Parisbased techbio company developing AIpowered digital twins of human cells and billion an AIpowered genomics company specializing in rare disease diagnostics and drug discovery today announced a codevelopment collaboration to discover and develop new smallmolecule therapeutics